Wang L, Kumar A, Das J, Ren Y, Peng H, Ballard D
Viruses. 2022; 14(8).
PMID: 36016335
PMC: 9414488.
DOI: 10.3390/v14081713.
Zutshi S, Kumar S, Chauhan P, Saha B
Methods Mol Biol. 2021; 2410:57-91.
PMID: 34914042
DOI: 10.1007/978-1-0716-1884-4_3.
Liu Q, Tian Y, Li Y, Zhang W, Cai W, Liu Y
J Immunother Cancer. 2020; 8(2).
PMID: 33323464
PMC: 7745518.
DOI: 10.1136/jitc-2020-001748.
Navelsaker S, Magadan S, Jouneau L, Quillet E, Olesen N, Munangandu H
Front Immunol. 2019; 10:2687.
PMID: 31824488
PMC: 6882293.
DOI: 10.3389/fimmu.2019.02687.
Lanzer K, Cookenham T, Reiley W, Blackman M
Immun Ageing. 2018; 15:17.
PMID: 30093911
PMC: 6081820.
DOI: 10.1186/s12979-018-0122-y.
Past Life and Future Effects-How Heterologous Infections Alter Immunity to Influenza Viruses.
Souquette A, Thomas P
Front Immunol. 2018; 9:1071.
PMID: 29872429
PMC: 5972221.
DOI: 10.3389/fimmu.2018.01071.
Alloimmunity But Not Viral Immunity Promotes Allograft Loss in a Mouse Model of Polyomavirus-Associated Allograft Injury.
Kim S, Wang J, Dong Y, Mathews D, Albrecht J, Breeden C
Transplant Direct. 2017; 3(6):e161.
PMID: 28620645
PMC: 5464780.
DOI: 10.1097/TXD.0000000000000677.
Human Asymptomatic Epitopes Identified from the Herpes Simplex Virus Tegument Protein VP13/14 (UL47) Preferentially Recall Polyfunctional Effector Memory CD44high CD62Llow CD8+ TEM Cells and Protect Humanized HLA-A*02:01 Transgenic Mice against....
Srivastava R, Khan A, Garg S, Syed S, Furness J, Vahed H
J Virol. 2016; 91(2).
PMID: 27847359
PMC: 5215341.
DOI: 10.1128/JVI.01793-16.
Reconstitution of CD8 T Cells Protective against Cytomegalovirus in a Mouse Model of Hematopoietic Cell Transplantation: Dynamics and Inessentiality of Epitope Immunodominance.
Holtappels R, Lemmermann N, Podlech J, Ebert S, Reddehase M
Front Immunol. 2016; 7:232.
PMID: 27379095
PMC: 4905951.
DOI: 10.3389/fimmu.2016.00232.
Vaccination and heterologous immunity: educating the immune system.
Gil A, Kenney L, Mishra R, Watkin L, Aslan N, Selin L
Trans R Soc Trop Med Hyg. 2015; 109(1):62-9.
PMID: 25573110
PMC: 4351360.
DOI: 10.1093/trstmh/tru198.
The two faces of heterologous immunity: protection or immunopathology.
Sharma S, Thomas P
J Leukoc Biol. 2013; 95(3):405-16.
PMID: 24212098
PMC: 3923083.
DOI: 10.1189/jlb.0713386.
Molecular docking analysis of 2009-H1N1 and 2004-H5N1 influenza virus HLA-B*4405-restricted HA epitope candidates: implications for TCR cross-recognition and vaccine development.
Su C, Schonbach C, Kwoh C
BMC Bioinformatics. 2013; 14 Suppl 2:S21.
PMID: 23368875
PMC: 3549837.
DOI: 10.1186/1471-2105-14-S2-S21.
Validation of cytomegalovirus immune competence assays for the characterization of CD8(+) T cell responses posttransplant.
Ravkov E, Pavlov I, Hanson K, Delgado J
Clin Dev Immunol. 2013; 2012:451059.
PMID: 23304188
PMC: 3530900.
DOI: 10.1155/2012/451059.
Allospecific CD4(+) effector memory T cells do not induce graft-versus-host disease in mice.
Zhang P, Wu J, Deoliveira D, Chao N, Chen B
Biol Blood Marrow Transplant. 2012; 18(10):1488-99.
PMID: 22809867
PMC: 3443280.
DOI: 10.1016/j.bbmt.2012.07.009.
Early priming minimizes the age-related immune compromise of CD8⁺ T cell diversity and function.
Valkenburg S, Venturi V, Dang T, Bird N, Doherty P, Turner S
PLoS Pathog. 2012; 8(2):e1002544.
PMID: 22383879
PMC: 3285595.
DOI: 10.1371/journal.ppat.1002544.
Enhancing alloreactivity does not restore GVHD induction but augments skin graft rejection by CD4⁺ effector memory T cells.
Anderson B, Tang A, Wang Y, Froicu M, Rothstein D, McNiff J
Eur J Immunol. 2011; 41(9):2782-92.
PMID: 21660940
PMC: 3517133.
DOI: 10.1002/eji.201141678.
The narrowing of the CD8 T cell repertoire in old age.
Blackman M, Woodland D
Curr Opin Immunol. 2011; 23(4):537-42.
PMID: 21652194
PMC: 3163762.
DOI: 10.1016/j.coi.2011.05.005.
Computer simulations of heterologous immunity: highlights of an interdisciplinary cooperation.
Calcagno C, Puzone R, Pearson Y, Cheng Y, Ghersi D, Selin L
Autoimmunity. 2011; 44(4):304-14.
PMID: 21271821
PMC: 3633596.
DOI: 10.3109/08916934.2010.523220.
Do viral infections protect from or enhance type 1 diabetes and how can we tell the difference?.
Christen U, von Herrath M
Cell Mol Immunol. 2011; 8(3):193-8.
PMID: 21258361
PMC: 4012874.
DOI: 10.1038/cmi.2010.71.
Heterologous immunity: immunopathology, autoimmunity and protection during viral infections.
Selin L, Wlodarczyk M, Kraft A, Nie S, Kenney L, Puzone R
Autoimmunity. 2011; 44(4):328-47.
PMID: 21250837
PMC: 3633594.
DOI: 10.3109/08916934.2011.523277.